Corporate wellness teams are under pressure to show that programmes genuinely improve employee health and engagement, not just tick boxes. Traditional initiatives – step challenges, webinars, generic health checks – can struggle to demonstrate meaningful, individualised impact. mescreen™ introduces a new layer: assessing mitochondrial efficiency as a proxy for cellular energy, resilience, and underlying wellbeing.

By offering employees a mescreen™ test, organisations can provide them with personalised, science-based insights into their cellular health, alongside clear lifestyle recommendations. This supports more targeted behaviour change around sleep, nutrition, stress management, and physical activity. It also helps employees feel that the company is investing in advanced tools, not just surface-level initiatives.

At a group level (with appropriate anonymisation and privacy safeguards), aggregated data can inform the design of more intelligent wellness strategies: for example, identifying overall trends in cellular resilience and aligning interventions accordingly. Over time, retesting can help demonstrate shifts across the workforce, supporting your wellbeing narrative and your business case.

For corporate wellness departments and their partners, mescreen™ can be integrated into executive health programmes, wellness days, or ongoing benefits. It is a high-perceived-value, relatively low-cost addition that reinforces your commitment to modern, preventative and performance-focused employee health.